Brief: Pharmather Receives Complete Response Letter From The U.S. Food And Drug Administration For Ketamine Abbreviated New Drug Application
23/10/2024 15:29
Oct 23 (Reuters) - Pharmather Holdings Ltd PHRM.CD :
* PHARMATHER RECEIVES COMPLETE RESPONSE LETTER FROM THE U.S.
FOOD
AND DRUG ADMINISTRATION FOR KETAMINE ABBREVIATED NEW DRUG
APPLICATION
Source text for Eikon: ID:nGNX1yNsyM
Further company coverage: PHRM.CD
((Reuters.Briefs@thomsonreuters.com))
Recent news on Pharmather Holdings
See all newsBrief: Pharmather Sells Ketamine ANDA, Eyes Over $25M In Milestone And Profit-Sharing Payments
Brief: Pharmather receives US FDA approval goal date for Ketamine
Brief: Pharmather Announces Update On FDA New Drug Application For Ketamine
Brief: PharmTther Announces Post Complete Response Letter Clarification Meeting Request Granted From The FDA For Ketamine Abbreviated New Drug Application
Brief: Pharmather Receives Complete Response Letter From The U.S. Food And Drug Administration For Ketamine Abbreviated New Drug Application